Comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 vs 17q24 2 Microdeletion Syndrome C5680185
Clinical comparison between 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia and 17q24 2 Microdeletion Syndrome for differential diagnosis and treatment planning.
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
An inherited disorder affecting adrenal hormone production, causing cortisol deficiency and other hormonal imbalances. Features may include ambiguous genitalia, salt-wasting crises, and growth issues. Treated with lifelong hormone replacement therapy.
17q24 2 Microdeletion Syndrome C5680185
A rare genetic disorder caused by deletion of genetic material on chromosome 17. Individuals may have developmental delays, facial features, and other medical issues. Care is supportive and multidisciplinary.
6 comparison axes
Onset
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
0-null
17q24 2 Microdeletion Syndrome C5680185
0-null
Onset patterns differ
Severity
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
severe
17q24 2 Microdeletion Syndrome C5680185
moderate
Different severity levels
Chronic
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
Chronic
17q24 2 Microdeletion Syndrome C5680185
Chronic
Differing course
Communicable
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
No
17q24 2 Microdeletion Syndrome C5680185
No
Different transmission
Body System
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
17q24 2 Microdeletion Syndrome C5680185
congenital
Same/different system
Category
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
17q24 2 Microdeletion Syndrome C5680185
genetic
Different category
Bottom line
21-hydroxylase-deficient-congenital-adrenal-hyperplasia-C2936858 and 17q24-2-microdeletion-syndrome-C5680185 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 17q24 2 Microdeletion Syndrome C5680185 | Discriminating power |
|---|---|---|---|
| Adrenal crisis or salt wasting | May occur, especially in severe 21-hydroxylase deficiency, with cortisol deficiency and possible aldosterone deficiency. | Not an established feature from the supplied description. | High |
| Genital or sex-development findings | Ambiguous genitalia may occur in affected genetic females because of androgen excess. | Not specifically established; other congenital findings may be present. | Moderate |
| Developmental delay and facial features | Not a defining feature; growth issues may occur. | Developmental delay, facial features, and other medical issues may occur. | Moderate |
When to favor each condition
Choose 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 when
Infant with suspected adrenal insufficiency or salt-wasting crisis
21-hydroxylase deficiency directly affects cortisol and may affect aldosterone production.
High
Newborn with atypical genitalia and suspected androgen excess
This pattern is recognized in 21-hydroxylase-deficient congenital adrenal hyperplasia.
Moderate
Abnormal newborn screening suggesting a congenital adrenal disorder
Screening can prompt endocrine evaluation, but a result is not itself a diagnosis.
Moderate
Choose 17q24 2 Microdeletion Syndrome C5680185 when
Developmental delay with congenital anomalies and no adrenal crisis
The supplied description emphasizes developmental, facial, and other medical issues.
Moderate
Chromosomal microarray suggests a 17q24.2 deletion
A confirmed deletion supports this genetic diagnosis over an adrenal enzyme disorder.
High
Family or clinician seeks syndrome-specific supportive care
Management is described as supportive and multidisciplinary rather than hormone replacement.
Moderate
How key tests differ
| Test | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 17q24 2 Microdeletion Syndrome C5680185 | Interpretation |
|---|---|---|---|
| Adrenal steroid evaluation | May show cortisol deficiency and a pattern suggesting 21-hydroxylase deficiency; exact cutoffs are not stated. | No characteristic adrenal pattern is established. | Abnormal results support endocrine referral but do not alone prove the diagnosis. |
| Genetic testing | Pathogenic CYP21A2 variants may confirm the inherited enzyme disorder. | Chromosomal microarray or equivalent testing may identify a 17q24.2 deletion. | The genetic method and result distinguish the conditions. |
| Electrolytes and glucose during illness | Salt wasting or hypoglycemia may occur in severe disease. | No specific electrolyte pattern is established. | Acute abnormalities need urgent clinical assessment and are not diagnostic by themselves. |
Prognosis comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
- Outcome
- Chronic condition that may be severe, with outcome depending on crisis prevention and hormone management.
- Factors
- Severity, salt wasting, adherence, illness planning, and growth or puberty monitoring.
17q24 2 Microdeletion Syndrome C5680185
- Outcome
- Chronic rare genetic condition described as moderate, but individual outcome is not established.
- Factors
- Extent of deletion, developmental needs, and associated medical issues.
Time frame: Both may begin early and require long-term follow-up; exact timelines are not established.
Diagnosis confirmation, associated complications, access to specialist care, and individual clinical course.
Complications comparison
| Complication | Presentation |
|---|---|
| Acute adrenal insufficiency | A recognized risk, particularly with illness, stress, or missed replacement. Not established from available information. Suspected adrenal crisis requires urgent clinician-directed care. |
| Growth and development concerns | Growth issues may occur and need endocrine follow-up. Developmental delay and other medical issues may occur. The mechanisms and expected course differ and are not fully defined here. |
| Associated congenital or medical problems | Mainly hormonal and sex-development effects are described. Facial features and other medical issues may require coordinated care. The microdeletion phenotype is sparsely specified and should not be overgeneralized. |
Patient education highlights
- HighUrgent illness plan
For suspected 21-hydroxylase deficiency, families should know when to seek urgent care for vomiting, lethargy, dehydration, or collapse.
- MediumDifferent causes
One condition is an adrenal hormone disorder; the other is a chromosomal deletion. Neither is communicable.
- MediumFollow-up
Lifelong hormone care may be needed for the adrenal disorder, while the microdeletion generally needs supportive multidisciplinary care.